Statin users without an APOE-epsilon4 allele have increased insulin resistance

J Alzheimers Dis. 2010;19(4):1149-53. doi: 10.3233/JAD-2010-1319.

Abstract

The present study examined the relationships among statin use, APOE genotype, and insulin resistance as measured by the homeostasis model assessment of insulin resistance (HOMA-IR) in healthy older adults. APOE epsilon4- (i.e., not having an epsilon4 allele) statin users had higher HOMA-IR values compared with epsilon4+/statin users (p=0.0169), and with non-users who were epsilon4- (p=0.0003) or epsilon4+ (p=0.0006). These results suggest that statin use may modulate insulin levels for individuals without an APOE epsilon4 allele.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Alzheimer Disease / epidemiology
  • Alzheimer Disease / genetics
  • Anticholesteremic Agents / therapeutic use*
  • Apolipoprotein E4 / genetics*
  • Dementia / epidemiology
  • Dementia / genetics
  • Diabetes Mellitus / epidemiology
  • Female
  • Genotype
  • Homeostasis
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Hypercholesterolemia* / drug therapy
  • Hypercholesterolemia* / epidemiology
  • Hypercholesterolemia* / genetics
  • Male
  • Metabolic Syndrome / epidemiology*
  • Prevalence

Substances

  • Anticholesteremic Agents
  • Apolipoprotein E4
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors